# A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients with Parkinson's Disease (PD)

> **NCT05258071** · PHASE2 · COMPLETED · sponsor: **Integrative Research Laboratories AB** · enrollment: 104 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Pirepemat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05258071
- **Lead sponsor:** Integrative Research Laboratories AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2024-12-04
- **Final completion:** 2025-01-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258071, "A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients with Parkinson's Disease (PD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05258071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*